Updated:
CHV Capital
CHV Capital is an early-stage investor focused on business opportunities serving a business or clinical need. The company provides venture capital guided by...
CHV Capital
CHV Capital is an early-stage investor focused on business opportunities serving a business or clinical need. The company provides venture capital guided by Indiana University Health's strategic objectives. CHV Capital has made 28 investments, including a Series A - II investment in Springbuk on June 28, 2017.
General information
Firm type
Venture Capital
Year founded
2008
Location
Region
North America
Country
United States
City
Indianapolis
Corporate office
Indianapolis, IN, United States
Sector focus
Frequently asked questions
Does CHV Capital invest only in Indiana-based companies?
No. While CHV Capital is rooted in the Indiana life-sciences ecosystem and has close ties to regional research institutions, the firm invests nationally in health-technology companies that can derive strategic value from a relationship with IU Health's clinical and operational infrastructure. Portfolio company pilots and clinical validation studies frequently occur inside IU Health facilities regardless of the company's headquarters.
How does being tied to an academic medical center affect CHV Capital's investment approach?
The IU Health affiliation gives CHV Capital a distinctive due-diligence and value-creation capability: companies can be evaluated by practicing clinicians, tested in real patient-care settings, and introduced to a concentrated base of potential enterprise customers. This clinical-integration model is rare among early-stage health-tech investors and functions as CHV Capital's primary sourcing and selection moat.
What investment stages does CHV Capital target?
The firm focuses primarily on early-stage companies — seed through Series B — with an emphasis on opportunities where clinical validation and health-system adoption are the next critical milestones. This aligns with the point at which IU Health's clinical-testing infrastructure provides the greatest strategic advantage.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: